期刊文献+

右美托咪啶预处理对大鼠自体原位肝移植术后肠道损伤的影响 被引量:5

Effects of Dexmedetomidine Preconditioning on Gut Injury after Orthotopic Autologous Liver Transplantation in Rats
下载PDF
导出
摘要 【目的】建立大鼠自体原位肝移植模型,探讨右美托咪啶(Dex)及其拮抗剂阿替美唑(Atip)预处理对大鼠自体原位肝移植术后肠道结构与功能改变的影响。【方法】48只成年SD大鼠,随机分为假手术组(S组)、模型组(M组)、低剂量Dex预处理组(D1组),高剂量Dex预处理组(D2组),低剂量Atip+低剂量Dex预处理组(A1组),高剂量Atip+高剂量Dex预处理组(A2组)。术后8 h留取末端回肠与动脉血,观察肠黏膜病理改变并行Chiu’s评分,ELISA法检测血清内毒素(LPS)水平与二胺氧化酶(DAO)活性,分光光度法测定肠道MDA含量与SOD活力,Western blotting法检测肠上皮紧密连接Occludin与ZO-1蛋白的表达。【结果】M组肠道病理损伤严重,LPS与MDA水平升高,紧密连接破坏;Dex预处理后,D2组较D1组肠道保护效应明显,LPS与MDA水平降低,SOD活力增强;相反,Atip+Dex预处理后,Dex肠道保护效应显著减弱。【结论】Dex预处理呈剂量依赖性地减轻大鼠自体原位肝移植术后的肠道损伤,可能与其抗炎、抗氧化作用密切相关。 [Objective] To establish a rat model of orthotopic autologous liver transplantation (OALT),and to investigate the effects of dexmedetomidine (Dex) and atipamezole (Atip) preconditioning on the changes of intestinal structure and function after OALT in rats.[Methods] Forty-eight adult Sprague-Dawley rats were randomly assigned into Sham group (group S),Model group (group M),low dosage Dex group (group D1),high dosage Dex group (group D2),low dosage Atip+ low dosage Dex group (group A1),high dosage Atip+ high dosage Dex group (group A2).Rats were sacrificed 8 h after the operation,and terminal ileum was harvested as to evaluate the intestinal mucosa histopathology.The level of serum lipopolysaccharide (LPS) and diamineoxidase (DAO) was tested by ELISA.Spectrophotometry assay for MDA and SOD,as well as Western-blotting for Occludin and ZO-1 expression on intestinal epithelium,was performed.[Results] The intestinal mucosa injury,and high level of LPS and MDA were clearly observed in group M.With Dex pretreatment,the gut injury was obviously attenuated,and Dex exerted anti-inflammatory and anti-oxidant effect,particularly in D2 group.Meanwhile,with Atip+Dex pretreatment,the beneficial effect of Dex was completely reversed.[Conclusion] Dex provided dose-dependent gut-protection for intestinal injury after OALT in rats.The anti-inflammatory and anti-oxidant effect of Dex,may majorly contributed to its gut-protective effect.
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2013年第6期845-850,共6页 Journal of Sun Yat-Sen University:Medical Sciences
基金 广东省科技计划项目(2009B030801125)
关键词 右美托咪啶 肝移植 肠道损伤 肠黏膜屏障 dexmedetomidine liver transplantation gut injury intestinal mucosal barrier
  • 相关文献

参考文献15

  • 1Brown KA,Moonka D.Liver transplantation[J].Curr Opin Gastroenterol,2004,20 (3):264-269.
  • 2Cao DQ,Chen YP,Li YG,et al.Treatment with total hepatic vascular exclusion and reperfusion for the intestinal barrier in rats[J].Cent South Univ:Med Sci,2005,30(4):433-436.
  • 3LiuDL,JeppsonB,HakanssonCH,etal.Multiple system organ damage resulting from prolonged hepatic inflow interruption[J].Arch Surg,1996,131 (4):442-447.
  • 4HoffmanWE,KochsE,WernerC,etal.Dexmedetomedine improve neurologic outcome from incomplete ischemia in the rat.Reversal by the α2-Adrenogic antagonist atipamezole[J].Anesthesiology,1991,75 (4):328-332.
  • 5Gu J,Sun P,Zhao H,Watts HR,et al.Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice[J].Crit Care,2011,15(3):R153.
  • 6Zhang XY,Liu ZM,Wen SH,et al.Dexmedetomidine administration before,but not after,ischemia attenuates intestinal injury induced by intestinal ischemia-reperfusion in rats[J].Anesthesiology,2012,116(5):1035-1046.
  • 7Kili(c) K,Hanci V,Selek S,et al.The effects of dexmedetomidine on mesenteric arterial occlusion-associated gut ischemia and reperfusion-induced gut and kidney injury in rabbits[J].J Surg Res,2012,178(1):223-232.
  • 8Chiu C J,McArdle AH,Brown R,et al.Intestinal mucosal lesion in low-flow states[J].Arch Surg,1970,101(4):478-483.
  • 9Carrico CJ,Meakins JL,Marshall JC.Multiple-organ-failure syndrome,the gastrointestinal tract:the "motor" of MOF[J].Arch Surg,1986,121(2):196-208.
  • 10Wilmore DW,Smith RJ,O'Dwyer S,et al.The gut:a central organ after surgical stress[J].Surgery,1988,104(5):917-923.

二级参考文献99

共引文献51

同被引文献93

  • 1赵俊.新编麻醉学[M].北京:人民军医出版社,2001.924.
  • 2British thoracic society bronehoscopy guidelines commit- tee. Brtish Thorocic society guideiines on diagmostic fiexi- biebronchoscopy [J]. Thorax ,2001,56(Suppl 1 ) : 11-21.
  • 3Bergese SD,Candiotti KA,Bokeseh PM,et al. A Phase IIIb, randomized, double -blind, placebo -controlled, muhicenter study evaluating the safety and efficacy of Dexmedetomi- dine for sedadonduring awake fiberoptic intubation [J]. Am J Ther,2010,17(6) :586-595.
  • 4Patel,Adavidson M,Tran MC,et al. Dexmedetomidine in- fuzion for analgesia and prevention of emergence agitation in children with obstructive sleep apnea syndrome under- going tonsillectomy and adenoideetomy [J]. Anesth Analg, 2010,111 (4) : 1004-1010.
  • 5Dere K,Sucullu I,Budak ET,et aL A eomparison of dexmedeto- midine versus midazolam for sedation,pain and hemody- namic control,during colonoscopy under conscious seda- tion [J]. Eur J Anaesthesiol,2010,27(7) :648-652.
  • 6Takimoto K,Ueda T,Shjmamoto F,et al. Sedation with dexmedetomidin hydrochloride during ednoscopic submu- cosal dissection of gastric cancer [J]. Digestvie endoscopy, 2011,4(2) : 176-181.
  • 7Pickies J, Jeffrey M, Datta A, et al. Is preparation for bronchoscopy optimai [J]. Eur Respir J, 2003,22 (2) : 203-206.
  • 8Tobias JD. Dexmedetomidine,applications in pediatric crit- ical care amd pediatric anesthesiology [J]. Pediart Crit Care Med,2007,8 (2) : 115-131.
  • 9Kim BG, Kang H. The Effect of Preemptive Perianal Ropivacaine and Ropivacaine with Dexmedetomidine on Pain after Hemorrhoidectomy: A Prospective, Randomized, Double-Blind,Placebo-Controlled Study. 76 (1):49-55. ndian J Surg. 2014.
  • 10Hu R, Liu JX, Jiang H. Dexmedetomidine versus remifentanil sedation during awake fiberoptic nasotracheal intubation: a double-blinded randomized controlled trial. J Anesth. 2013;27 (2):211-217.

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部